by Andreu Prados
While patients infected with SARS-CoV-2 typically present with a respiratory illness, certain patients also report gastrointestinal symptoms. The presence of virus receptors in gastrointestinal epithelial cells and an altered gut microbiota composition in some patients might have implications for managing COVID-19.
by GMFH Editing Team
Meal residues entering the colon are metabolized by the gut microbiota and may lead to functional digestive symptoms in the general population. New research shows that probiotics may help improve the tolerance of a plant-based flatulogenic diet.
by GMFH Editing Team
Important scientific progress has been made in 2019 in our understanding of the contribution of gut microbiome in health and disease. Have a look at this “2019 Year at a glance” report and discover the year’s breakthroughs in the field.
by GMFH Editing Team
The current management of functional abdominal pain in children is inconsistent. Summary evidence from three Cochrane systematic reviews of randomized clinical trials concludes that probiotics, cognitive behavioral therapy and hypnotherapy may be effective in this regard.
by GMFH Editing Team
Gibson and Roberfroid were the first to anticipate that probiotics and prebiotics could be combined as synbiotics back in 1995. Mary Ellen Sanders and Andreu Prados introduce our new selection of human research on the health benefits of synbiotics.
by GMFH Editing Team
Gut health has emerged as a potential target in people suffering from metabolic syndrome. A new randomized controlled trial has found that yogurt may help ameliorate insulin resistance in obese women with nonalcoholic fatty liver disease and metabolic syndrome by involving the gut microbiota.
by GMFH Editing Team
Nowadays it’s difficult to keep abreast of everything that’s going on in probiotics and prebiotics research. Five of the world’s leading scientists in the field summarizes the clinical application and use in humans of prebiotics and probiotics.
Identifying high quality probiotics available in the marketplace isn’t an easy task. A recent panel of experts suggest some recommendations to companies producing probiotics for assuring probiotics’ quality, from their manufacture to their selling.
The last 8th Gut Microbiota for Health World Summit hold in Miami in March updated the science behind gut microbiota and diet, probiotics, functional gastrointestinal disorders and metabolic and liver conditions. Check out here the Summit’s official report.
by GMFH Editing Team
To what extent targeting the gut microbiota as a potential treatment for depression and anxiety is unknown. A new systematic review and meta-analysis of 34 controlled clinical trials concludes that probioticsbut not prebioticsmay exert potential antidepressant and anxiolytic effects.
